Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
PBYI · NASDAQ · Pharmaceutical Preparations
$7.05−0.07 (−0.98%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Puma Biotechnology (PBYI) · oqro.io/stocks/PBYI · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
American Century Investment Management, Inc. now owns 5.3% of PBYI as a passive investorSourceInsider trade · Traded Nov 11, 2026 · Filed Nov 14, 2026
Director sold ~$121K of PBYI shares in the open marketSourcePlanned sale · Planned for Nov 11, 2026 · Notice filed Nov 12, 2026
Director filed to sell about $121K of PBYI stockSource5%+ stake, activist · Stake as of Oct 4, 2026 · Filed Oct 6, 2026
Alan H. Auerbach disclosed a 16% stake in PBYI and may seek to influence the companySourceInsider trade · Traded Sep 14, 2026 · Filed Sep 17, 2026
Director sold ~$567K of PBYI shares in the open marketSourceInsider trade · Traded Sep 14, 2026 · Filed Sep 17, 2026
Director sold ~$46K of PBYI shares in the open marketSourceInsider trade · Traded Jul 6, 2026 · Filed Jul 9, 2026
CEO sold ~$364K of PBYI shares in the open marketSourceInsider trade · Traded Jul 6, 2026 · Filed Jul 9, 2026
CFO sold ~$78K of PBYI shares in the open marketSourceInsider trade · Traded Jul 6, 2026 · Filed Jul 9, 2026
Officer sold ~$70K of PBYI shares in the open marketSourceInsider trade · Traded Jun 12, 2026 · Filed Jun 16, 2026
Director sold ~$194K of PBYI shares in the open marketSourceInsider trade · Traded Jun 12, 2026 · Filed Jun 16, 2026
Director sold ~$159K of PBYI shares in the open marketSourceInsider trade · Traded Jun 12, 2026 · Filed Jun 16, 2026
Director sold ~$84K of PBYI shares in the open marketSourceInsider trade · Traded Jun 12, 2026 · Filed Jun 16, 2026
Director sold ~$78K of PBYI shares in the open marketSourceInsider trade · Traded Jan 7, 2026 · Filed Jan 9, 2026
CEO sold ~$106K of PBYI shares in the open marketSourceInsider trade · Traded Jan 6, 2026 · Filed Jan 9, 2026
CEO sold ~$99K of PBYI shares in the open marketSourceInsider trade · Traded Jan 7, 2026 · Filed Jan 9, 2026
CFO sold ~$38K of PBYI shares in the open marketSourceInsider trade · Traded Jan 6, 2026 · Filed Jan 9, 2026
CFO sold ~$27K of PBYI shares in the open marketSourceInsider trade · Traded Nov 11, 2025 · Filed Nov 14, 2025
Director sold ~$97K of PBYI shares in the open marketSourceInsider trade · Traded Jul 18, 2025 · Filed Jul 22, 2025
Director sold ~$91K of PBYI shares in the open marketSourceInsider trade · Traded Jul 8, 2025 · Filed Jul 11, 2025
CEO sold ~$90K of PBYI shares in the open marketSourceInsider trade · Traded Jul 9, 2025 · Filed Jul 11, 2025
CEO sold ~$76K of PBYI shares in the open marketSourceInsider trade · Traded Jul 8, 2025 · Filed Jul 11, 2025
CFO sold ~$20K of PBYI shares in the open marketSourceInsider trade · Traded Jun 13, 2025 · Filed Jun 17, 2025
Director sold ~$92K of PBYI shares in the open marketSourceInsider trade · Traded Jun 13, 2025 · Filed Jun 17, 2025
Director sold ~$75K of PBYI shares in the open marketSourceInsider trade · Traded Jun 13, 2025 · Filed Jun 17, 2025
Director sold ~$41K of PBYI shares in the open marketSourceInsider trade · Traded Jun 13, 2025 · Filed Jun 17, 2025
Director sold ~$39K of PBYI shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 18, 2025
Frazier Life Sciences Management, L.P. no longer reported PBYI for Q4 2024SourceInsider trade · Traded Jan 2, 2025 · Filed Jan 4, 2025
CEO sold ~$107K of PBYI shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 4, 2025
CFO sold ~$32K of PBYI shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 4, 2025
Officer sold ~$30K of PBYI shares in the open marketSourceInsider trade · Traded Jan 2, 2025 · Filed Jan 4, 2025
Officer sold ~$27K of PBYI shares in the open marketSourceInsider trade · Traded Jun 12, 2026 · Filed Jun 16, 2026
Director sold ~$58K of PBYI shares in the open marketSourceInsider trade · Traded Jan 7, 2026 · Filed Jan 9, 2026
Officer sold ~$29K of PBYI shares in the open marketSourceInsider trade · Traded Jan 6, 2026 · Filed Jan 9, 2026
Officer sold ~$23K of PBYI shares in the open marketSourceInsider trade · Traded Jul 9, 2025 · Filed Jul 11, 2025
CFO sold ~$14K of PBYI shares in the open marketSourceInsider trade · Traded Jul 8, 2025 · Filed Jul 11, 2025
Officer sold ~$15K of PBYI shares in the open marketSourceInsider trade · Traded Jul 9, 2025 · Filed Jul 11, 2025
Officer sold ~$12K of PBYI shares in the open marketSourceInsider trade · Traded Jun 13, 2025 · Filed Jun 17, 2025
Director sold ~$37K of PBYI shares in the open marketSourceInsider trade · Traded Jun 13, 2025 · Filed Jun 17, 2025
Director sold ~$27K of PBYI shares in the open marketSource